Rani Therapeutics Holdings Inc - Class A

NEW
NAS:RANI (USA)   Class A
$ 2.29 -0.03 (-1.29%) 04:00 PM EST
At Loss
P/B:
21.82
Market Cap:
$ 74.40M
Enterprise V:
$ 80.21M
Volume:
381.56K
Avg Vol (2M):
2.35M
Trade In:
Volume:
381.56K
At Loss
Avg Vol (2M):
2.35M

Business Description

Rani Therapeutics Holdings Inc
NAICS : 541713 SIC : 2833
ISIN : US7530181004

Share Class Description:

RANI: Class A
Description
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.
Name Current Vs Industry Vs History
Cash-To-Debt 0.88
Equity-to-Asset 0.07
Debt-to-Equity 12.43
Debt-to-EBITDA -0.65
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 43.44
9-Day RSI 47.23
14-Day RSI 47.99
6-1 Month Momentum % -66.14
12-1 Month Momentum % 10.2

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.93
Quick Ratio 1.93
Cash Ratio 1.86

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.6
Shareholder Yield % -8.02

Profitability Rank

Name Current Vs Industry Vs History
ROE % -236.18
ROA % -49.47
ROIC % -364.6
3-Year ROIIC % -1164.63
ROC (Joel Greenblatt) % -621.97
ROCE % -107.23

Financials (Next Earnings Date:2024-11-08 Est.)

RANI's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RANI

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Rani Therapeutics Holdings Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.18
Beta -0.02
Volatility % 142.91
14-Day RSI 47.99
14-Day ATR ($) 0.313403
20-Day SMA ($) 2.40825
12-1 Month Momentum % 10.2
52-Week Range ($) 1.82 - 8.75
Shares Outstanding (Mil) 32.49

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Rani Therapeutics Holdings Inc Filings

Filing Date Document Date Form
No Filing Data

Rani Therapeutics Holdings Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Rani Therapeutics Holdings Inc Frequently Asked Questions

What is Rani Therapeutics Holdings Inc(RANI)'s stock price today?
The current price of RANI is $2.29. The 52 week high of RANI is $8.75 and 52 week low is $1.82.
When is next earnings date of Rani Therapeutics Holdings Inc(RANI)?
The next earnings date of Rani Therapeutics Holdings Inc(RANI) is 2024-11-08 Est..
Does Rani Therapeutics Holdings Inc(RANI) pay dividends? If so, how much?
Rani Therapeutics Holdings Inc(RANI) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1